The Effect of Extrinsic Factors on Food Allergy (Ex-Factor)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Food allergy is a common problem, affecting 5-8% of the population. Peanut allergy causes reduced quality of life due to the perceived high risk of severe reactions. Patients rely on accurate labeling of both loose and pre-packed foods, but these are often ambiguous and unhelpful. There is a common conception that labeling is 'over-cautious'. Peanut-allergic consumers face increasingly restricted food choices in complying with this advice due, in part, to the proliferation of advisory labels such as 'may contain peanuts'. This contributes to the reduces quality of life of affected individuals.
For industry to provide more accurate and helpful labeling, certain characteristics of the food-allergic population need to be defined. Firstly, the minimum 'eliciting dose' for the population has been estimated by studying large groups of peanut allergic patients who are challenged with peanut ingestion in increasing amounts. From these, an eliciting dose that provokes a reaction in 10% of the food-allergic population has been estimated at between six and 14mg of peanut protein.
Translation of population eliciting doses (ED) into acceptable levels of allergen contamination for the population requires consideration of a 'safety factor'- to account for individual variability in dose threshold and severity. Data suggest such variability depends in part on extrinsic factors (exercise and sleep restriction). Each factor may have a different effect in scale and direction. The investigators are proposing a cross-over trial with 85 peanut-allergic adults who will each undergoing a baseline peanut challenge followed by repeat challenges with extrinsic factors applied, in random order (repeat baseline, +exercise and +sleep restriction). These data will further define ED for the UK population and a safety factor derived from shift in threshold, to inform industry and protect the allergic population.
| Condition | Intervention | Phase |
|---|---|---|
|
Peanut Hypersensitivity |
Other: Food challenge |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) |
| Official Title: | The Effect of Extrinsic Factors on Food Allergy |
- minimum amount of peanut protein in milligrams which causes an objective clinical reaction during peanut challenges [ Time Frame: 36 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 100 |
| Study Start Date: | October 2012 |
| Estimated Study Completion Date: | October 2015 |
| Estimated Primary Completion Date: | September 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Arm 1
Exercise followed by sleep restriction followed by control challenge
|
Other: Food challenge
Double blind placebo controlled peanut challenge. Each challenge given with or without extrinsic factors exercise or sleep restriction.
Other Name: Threshold extrinsic factor challenges
|
|
Experimental: Arm 2
Sleep restriction followed by exercise followed by control challenge
|
Other: Food challenge
Double blind placebo controlled peanut challenge. Each challenge given with or without extrinsic factors exercise or sleep restriction.
Other Name: Threshold extrinsic factor challenges
|
|
Experimental: Arm 3
control followed by sleep restriction followed by exercise
|
Other: Food challenge
Double blind placebo controlled peanut challenge. Each challenge given with or without extrinsic factors exercise or sleep restriction.
Other Name: Threshold extrinsic factor challenges
|
|
Experimental: Arm 4
control followed by exercise followed by sleep restriction
|
Other: Food challenge
Double blind placebo controlled peanut challenge. Each challenge given with or without extrinsic factors exercise or sleep restriction.
Other Name: Threshold extrinsic factor challenges
|
|
Experimental: Arm 5
Sleep Restriction followed by control followed by exercise
|
Other: Food challenge
Double blind placebo controlled peanut challenge. Each challenge given with or without extrinsic factors exercise or sleep restriction.
Other Name: Threshold extrinsic factor challenges
|
|
Experimental: Arm 6
Exercise followed by control followed by sleep restriction
|
Other: Food challenge
Double blind placebo controlled peanut challenge. Each challenge given with or without extrinsic factors exercise or sleep restriction.
Other Name: Threshold extrinsic factor challenges
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Written informed consent must be obtained before any assessment is performed.
- Male and female subject who are 18-45 years of age at the time of study entry (Visit 1) who have a diagnosis of acute peanut allergy as manifested by urticaria, angioedema or respiratory/gastrointestinal tract symptoms, with acute onset of symptoms after ingestion (up to 2h).
- A positive peanut DBPCFC at baseline (Visit 1). This outcome is defined as the onset of objective allergic events after ingestion of peanut protein but not to the placebo. Eligibility to the DBPCFC requires fulfillment of all other eligibility criteria at visit 1.
- Subjects must be able to comply with the study procedures.
Contacts and Locations| Contact: Andrew T Clark, MB BS MD | +44 1223 762603 | andrew.clark@addenbrookes.nhs.uk |
| United Kingdom | |
| Addenbrooke's Hospital | Not yet recruiting |
| Cambridge, Cambs, United Kingdom, CB2 2QQ | |
| Principal Investigator: Andrew T Clark, MB BS MD | |
| Imperial College | Not yet recruiting |
| London, United Kingdom, W2 1PG | |
| Contact: Robert Boyle, MB BS PhD | |
| Study Director: | Andrew T Clark, MB BS MD | Cambridge University Hospitals NHS Trust |
More Information
Publications:
| Responsible Party: | Dr. Andrew Clark, Associate Lecturer and Consultant in Paediatric Allergy, Cambridge University Hospitals NHS Foundation Trust |
| ClinicalTrials.gov Identifier: | NCT01429896 History of Changes |
| Other Study ID Numbers: | 01.31.09.2011 |
| Study First Received: | August 31, 2011 |
| Last Updated: | April 3, 2012 |
| Health Authority: | United Kingdom: National Health Service |
Keywords provided by Cambridge University Hospitals NHS Foundation Trust:
|
peanut allergy food allergy thresholds anaphylaxis |
food labelling food challenges peanut challenges |
Additional relevant MeSH terms:
|
Food Hypersensitivity Hypersensitivity Peanut Hypersensitivity Hypersensitivity, Immediate Immune System Diseases |
ClinicalTrials.gov processed this record on May 16, 2013